Sanofi: Information concerning the total number of voting rights and shares – October 2023
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Pharmaceuticals, Biotechnology and Life Sciences
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Bagsværd, Denmark, 23 November 2023 – Novo Nordisk today announced the investment of more than 16 billion Danish kroner (2.1…
ST. LOUIS, Nov. 23, 2023 (GLOBE NEWSWIRE) — Curium, a global leader in nuclear medicine, announced today the successful completion…
MC2 Therapeutics Announces First Patients Enrolled in Phase 2 Proof of Concept Clinical Trial in Vulvar Lichen Sclerosus MC2-25 VLS…
MC2 Therapeutics Announces First Patients Enrolled in Phase 2 Proof of Concept Clinical Trial in Vulvar Lichen Sclerosus MC2-25 VLS…
Geneva, Switzerland, November 23, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…
SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a…
Bright Green has achieved several key milestones throughout the Quarter advancing progress against its strategic plan. Continued marketing of its…
BRISBANE, Calif., Nov. 22, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class…
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in…